E. Desport, F. Bridoux, C. Sirac, S. Delbes, S. Bender et al., AL Amyloidosis, Orphanet Journal of Rare Diseases, vol.7, issue.1, p.54, 2012.
DOI : 10.1038/nature09494

URL : https://hal.archives-ouvertes.fr/hal-00903818

S. Banypersad, J. Moon, C. Whelan, P. Hawkins, and A. Wechalekar, Updates in Cardiac Amyloidosis: A Review, Journal of the American Heart Association, vol.1, issue.2, pp.364-000364, 2012.
DOI : 10.1161/JAHA.111.000364

D. Bodez, J. Deux, J. Rosso, C. Tissot, S. Guendouz et al., L'amylose cardiaque, une maladie pas si rare ! Arch Mal Coeur Vaiss -Prat, avr, vol.2014, issue.227, p.1322, 2014.

B. Esplin and M. Gertz, Current Trends in Diagnosis and Management of Cardiac Amyloidosis, Current Problems in Cardiology, vol.38, issue.2, p.5396, 2013.
DOI : 10.1016/j.cpcardiol.2012.11.002

M. Fikrle, T. Pale?ek, P. Kuchynka, E. N?me?ek, L. Bauerová et al., Cardiac amyloidosis: A comprehensive review, Cor et Vasa, vol.55, issue.1, p.6075, 2013.
DOI : 10.1016/j.crvasa.2012.11.018

J. Selvanayagam, P. Hawkins, B. Paul, S. Myerson, and S. Neubauer, Evaluation and Management of the Cardiac Amyloidosis, Journal of the American College of Cardiology, vol.50, issue.22, p.210110, 2007.
DOI : 10.1016/j.jacc.2007.08.028

R. Falk, R. Comenzo, and M. Skinner, The Systemic Amyloidoses, New England Journal of Medicine, vol.337, issue.13, p.898909, 1997.
DOI : 10.1056/NEJM199709253371306

D. Feng, W. Edwards, J. Oh, K. Chandrasekaran, M. Grogan et al., Intracardiac Thrombosis and Embolism in Patients With Cardiac Amyloidosis, Circulation, vol.116, issue.21, p.24206, 2007.
DOI : 10.1161/CIRCULATIONAHA.107.697763

N. Colignon, C. Phan, and J. Cazejust, Imagerie de l'amylose: revue iconographique Disponible sur: http://pe.sfrnet.org/Data, Journ Fr Radiol [Internet], vol.1, 2011.

K. Sloan, C. Bruce, J. Oh, and C. Rihal, Complications of Echocardiography-Guided Endomyocardial Biopsy, Journal of the American Society of Echocardiography, vol.22, issue.3, pp.324-338, 2009.
DOI : 10.1016/j.echo.2008.12.023

C. Quarta, J. Kruger, and R. Falk, Cardiac Amyloidosis. Circulation, p.17882, 2012.

S. Dubrey, Amyloid heart disease: a brief review of treatment options, Postgraduate Medical Journal, vol.88, issue.1046, p.7005, 1046.
DOI : 10.1136/postgradmedj-2012-130854

M. Fontana, S. Pica, P. Reant, A. Gadir, T. Treibel et al., Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis, Circulation. 11 sept, 2015.

A. Bhuva, T. Treibel, M. Fontana, A. Herrey, C. Manisty et al., T1 mapping: non-invasive evaluation of myocardial tissue composition by cardiovascular magnetic resonance, Expert Review of Cardiovascular Therapy, vol.12, issue.12, p.145564, 2014.
DOI : 10.1586/14779072.2014.986098

S. Giri, Y. Chung, A. Merchant, G. Mihai, S. Rajagopalan et al., T2 quantification for improved detection of myocardial edema, Journal of Cardiovascular Magnetic Resonance, vol.11, issue.1, p.56, 2009.
DOI : 10.1186/1532-429X-11-56

S. Banypersad, J. Moon, C. Whelan, P. Hawkins, and A. Wechalekar, Updates in Cardiac Amyloidosis: A Review, Journal of the American Heart Association, vol.1, issue.2, pp.364-000364, 2012.
DOI : 10.1161/JAHA.111.000364

J. Selvanayagam, P. Hawkins, B. Paul, S. Myerson, and S. Neubauer, Evaluation and Management of the Cardiac Amyloidosis, Journal of the American College of Cardiology, vol.50, issue.22, p.210110, 2007.
DOI : 10.1016/j.jacc.2007.08.028

B. Esplin and M. Gertz, Current Trends in Diagnosis and Management of Cardiac Amyloidosis, Current Problems in Cardiology, vol.38, issue.2, p.5396, 2013.
DOI : 10.1016/j.cpcardiol.2012.11.002

R. Falk, Cardiac Amyloidosis: A Treatable Disease, Often Overlooked, Circulation, vol.124, issue.9, p.107985, 2011.
DOI : 10.1161/CIRCULATIONAHA.110.010447

B. Austin, W. Tang, E. Rodriguez, C. Tan, S. Flamm et al., Delayed Hyper-Enhancement Magnetic Resonance Imaging Provides Incremental Diagnostic and Prognostic Utility in Suspected Cardiac Amyloidosis, JACC: Cardiovascular Imaging, vol.2, issue.12, p.136977, 2009.
DOI : 10.1016/j.jcmg.2009.08.008

A. Maceira, S. Prasad, P. Hawkins, M. Roughton, and D. Pennell, Cardiovascular Magnetic Resonance and prognosis in cardiac amyloidosis, Journal of Cardiovascular Magnetic Resonance, vol.10, issue.1, p.54, 2008.
DOI : 10.1186/1532-429X-10-54

A. Maceira, J. Joshi, S. Prasad, J. Moon, E. Perugini et al., Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation, p.18693, 2005.

I. Syed, J. Glockner, D. Feng, P. Araoz, M. Martinez et al., Role of Cardiac Magnetic Resonance Imaging in the Detection of Cardiac Amyloidosis, JACC: Cardiovascular Imaging, vol.3, issue.2, p.15564, 2010.
DOI : 10.1016/j.jcmg.2009.09.023

H. Vogelsberg, H. Mahrholdt, C. Deluigi, A. Yilmaz, E. Kispert et al., Cardiovascular Magnetic Resonance in Clinically Suspected Cardiac Amyloidosis, Journal of the American College of Cardiology, vol.51, issue.10, p.102230, 2008.
DOI : 10.1016/j.jacc.2007.10.049

E. Dall-'armellina, S. Piechnik, V. Ferreira, Q. Si, M. Robson et al., Cardiovascular magnetic resonance by non contrast T1-mapping allows assessment of severity of injury in acute myocardial infarction, Journal of Cardiovascular Magnetic Resonance, vol.14, issue.1, p.15, 2012.
DOI : 10.1186/1532-429X-11-56

S. Dass, J. Suttie, S. Piechnik, V. Ferreira, C. Holloway et al., Myocardial Tissue Characterization Using Magnetic Resonance Noncontrast T1 Mapping in Hypertrophic and Dilated Cardiomyopathy, Circulation: Cardiovascular Imaging, vol.5, issue.6, p.72633, 2012.
DOI : 10.1161/CIRCIMAGING.112.976738

M. Gertz, R. Comenzo, R. Falk, J. Fermand, B. Hazenberg et al., Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis, AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, p.31928, 2004.

S. Piechnik, V. Ferreira, E. Dall-'armellina, L. Cochlin, A. Greiser et al., Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold, Journal of Cardiovascular Magnetic Resonance, vol.12, issue.1, p.69, 2010.
DOI : 10.1186/1532-429X-12-69

D. Messroghli, A. Radjenovic, S. Kozerke, D. Higgins, M. Sivananthan et al., Modified Look-Locker inversion recovery (MOLLI) for high-resolutionT1 mapping of the heart, Magnetic Resonance in Medicine, vol.97, issue.1, p.1416, 2004.
DOI : 10.1002/mrm.20110

S. Giri, Y. Chung, A. Merchant, G. Mihai, S. Rajagopalan et al., T2 quantification for improved detection of myocardial edema, Journal of Cardiovascular Magnetic Resonance, vol.11, issue.1, p.56, 2009.
DOI : 10.1186/1532-429X-11-56

T. Huang, Y. Liu, A. Stemmer, and B. Poncelet, T2 measurement of the human myocardium using aT2-prepared transient-state trueFISP sequence, Magnetic Resonance in Medicine, vol.52, issue.5, pp.960-966, 2007.
DOI : 10.1002/mrm.21208

T. Karamitsos, L. Hudsmith, J. Selvanayagam, S. Neubauer, and J. Francis, Operator Induced Variability in Left Ventricular Measurements with Cardiovascular Magnetic Resonance is Improved After Training, Journal of Cardiovascular Magnetic Resonance, vol.9, issue.5, pp.777-83, 2007.
DOI : 10.1080/10976640701545073

M. Fontana, S. Pica, P. Reant, A. Gadir, T. Treibel et al., Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis, Circulation. 11 sept, 2015.

M. Fontana, R. Chung, P. Hawkins, and J. Moon, Cardiovascular magnetic resonance for amyloidosis, Heart Failure Reviews, vol.19, issue.9, pp.133-177, 2015.
DOI : 10.1007/s10741-014-9470-7

T. Karamitsos, S. Piechnik, S. Banypersad, M. Fontana, N. Ntusi et al., Noncontrast T1 Mapping for the Diagnosis of Cardiac Amyloidosis, JACC: Cardiovascular Imaging, vol.6, issue.4, pp.488-97, 2013.
DOI : 10.1016/j.jcmg.2012.11.013

. Germain, S. El-ghannudi, M. Jeung, P. Ohlmann, E. Epailly et al., Native T1 Mapping of the Heart – A Pictorial Review, Clin Med Insights Cardiol. déc, vol.1, 2014.

P. Sparrow, A. Amirabadi, M. Sussman, N. Paul, and N. Merchant, Quantitative assessment of myocardial T2 relaxation times in cardiac amyloidosis, Journal of Magnetic Resonance Imaging, vol.118, issue.5, pp.942-948, 2009.
DOI : 10.1002/jmri.21918

M. Fontana, S. Banypersad, T. Treibel, V. Maestrini, D. Sado et al., Native T1 Mapping in Transthyretin Amyloidosis, JACC: Cardiovascular Imaging, vol.7, issue.2, pp.157-65, 2014.
DOI : 10.1016/j.jcmg.2013.10.008

L. Robbers, E. Baars, W. Brouwer, A. Beek, M. Hofman et al., T1 Mapping Shows Increased Extracellular Matrix Size in the Myocardium Due to Amyloid Depositions, Circulation: Cardiovascular Imaging, vol.5, issue.3, pp.423-429, 2012.
DOI : 10.1161/CIRCIMAGING.112.973438

M. Ugander, A. Oki, L. Hsu, P. Kellman, A. Greiser et al., Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology, European Heart Journal, vol.33, issue.10, pp.1268-78, 2012.
DOI : 10.1093/eurheartj/ehr481

A. Barison, G. Aquaro, N. Pugliese, F. Cappelli, S. Chiappino et al., Measurement of myocardial amyloid deposition in systemic amyloidosis: insights from cardiovascular magnetic resonance imaging, Journal of Internal Medicine, vol.1, issue.5, pp.605-619, 2015.
DOI : 10.1111/joim.12324

S. Banypersad, M. Fontana, V. Maestrini, D. Sado, G. Captur et al., T1 mapping and survival in systemic light-chain amyloidosis, European Heart Journal, vol.36, issue.4, pp.244-51, 2015.
DOI : 10.1093/eurheartj/ehu444

S. Banypersad, D. Sado, A. Flett, S. Gibbs, J. Pinney et al., Quantification of Myocardial Extracellular Volume Fraction in Systemic AL Amyloidosis: An Equilibrium Contrast Cardiovascular Magnetic Resonance Study, Circulation: Cardiovascular Imaging, vol.6, issue.1
DOI : 10.1161/CIRCIMAGING.112.978627